Attenuated Modified Vaccinia Virus Ankara Can Be Used as an Immunizing Agent under Conditions of Preexisting Immunity to the Vector
A problem associated with the use of vaccinia virus recombinants as vaccines is the existence of a large human population with preexisting immunity to the vector. Here we showed that after a booster with attenuated recombinant modified vaccinia virus Ankara (rMVA), higher humoral and cellular immune...
Guardat en:
| Publicat a: | J Virol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
2000
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC112288/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10906221/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.74.16.7651-7655.2000 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|